| Abbreviation | Full Name |
| AAV9 | adeno-associated virus serotype 9 |
| ABT263 | navitoclax |
| ACAN | aggrecan |
| ACLT | anterior cruciate ligament transection |
| ADAMTS5 | a disintegrin and metalloproteinase with thrombospondin motifs 5 |
| ADSC | adipose-derived mesenchymal stem cell |
| AKT | AKT serine/threonine kinase |
| AMPK | adenosine monophosphate-activated protein kinase |
| AngC-2 | angiogenic chondrocyte-2 |
| ARF6 | ADP-ribosylation factor 6 |
| AuNPs | gold nanoparticles |
| BMEC | bone marrow endothelial cell |
| BMP-2 | bone morphogenetic protein-2 |
| BMSC | bone marrow mesenchymal stem cell |
| Bu-Sui-Dan | Bu-Sui-Dan (traditional Chinese medicine formulation) |
| CALCRL | calcitonin receptor-like receptor |
| CD31 | platelet endothelial cell adhesion molecule-1 |
| CD90 | cluster of differentiation 90 |
| CD146 | cluster of differentiation 146 |
| COL I | collagen type I |
| COL II | collagen type II |
| COL X | collagen type X |
| COL2A1 | collagen type II alpha 1 chain |
| COL10A1 | collagen type X alpha 1 chain |
| CPC | calcium phosphate cement |
| CRISPR-Cas9 | clustered regularly interspaced short palindromic repeats–CRISPR-associated protein 9 |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| DBM | demineralized bone matrix |
| DFO | deferoxamine |
| DLL4 | delta-like canonical Notch ligand 4 |
| DMM | destabilization of the medial meniscus |
| EGFR | epidermal growth factor receptor |
| EMCN | endomucin |
| eNOS | endothelial nitric oxide synthase |
| Epas1 | endothelial PAS domain protein 1 |
| EP4 | E-prostanoid 4 receptor |
| EPC | endothelial progenitor cell |
| FAK | focal adhesion kinase |
| FGF2 | fibroblast growth factor 2 |
| FGFR2 | fibroblast growth factor receptor 2 |
| FOXO1 | forkhead box O1 |
| GelMA | gelatin methacryloyl |
| GLI-1 | glioma-associated oncogene homolog-1 |
| GPX4 | glutathione peroxidase 4 |
| GRK2 | G protein-coupled receptor kinase 2 |
| GSH | glutathione |
| HIF-1α | hypoxia-inducible factor 1-alpha |
| HIF-2α | hypoxia-inducible factor 2-alpha |
| HIF-3α | hypoxia-inducible factor 3-alpha |
| HSP90 | heat shock protein 90 |
| HUVEC | human umbilical vein endothelial cell |
| IHH | Indian hedgehog |
| IL-1β | interleukin-1 beta |
| IL-2 | interleukin-2 |
| IL-6 | interleukin-6 |
| IL-18 | interleukin-18 |
| KOA | knee osteoarthritis |
| Lcp1 | lymphocyte cytosolic protein 1 |
| LL-37 | cathelicidin LL-37 |
| LncHIFCAR | long noncoding HIF-1α co-activating RNA |
| LOX-1 | lectin-like oxidized low-density lipoprotein receptor-1 |
| M1 | classically activated macrophage |
| MAPK | mitogen-activated protein kinase |
| miR | microRNA |
| miR-29a-3p | microRNA-29a-3p |
| miR-29cb2 | microRNA-29cb2 |
| miR-148b-3p | microRNA-148b-3p |
| MMP | matrix metalloproteinase |
| mTOR | mechanistic target of rapamycin |
| mTORC1 | mechanistic target of rapamycin complex 1 |
| MXene (Nb2C) | niobium carbide MXene |
| NAPVSIPQ | Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln |
| NF-κB | nuclear factor kappa B |
| NIPAM | N-isopropylacrylamide |
| Notch | Notch receptor |
| OA | osteoarthritis |
| OARSI | Osteoarthritis Research Society International |
| OCN | osteocalcin |
| OPN | osteopontin |
| Osx | Osterix |
| OVX | ovariectomized |
| p16 | cyclin-dependent kinase inhibitor 2A |
| p21 | cyclin-dependent kinase inhibitor 1A |
| p53 | tumor protein p53 |
| PAK1 | p21-activated kinase 1 |
| PCL-SE | polycaprolactone scaffold modified with EPLQLKM and SVVYGLR peptides |
| PDGF-BB | platelet-derived growth factor BB |
| PDGFR-β | platelet-derived growth factor receptor beta |
| PHD2 | prolyl hydroxylase domain-containing protein 2 |
| PI3K | phosphoinositide 3-kinase |
| Plexin-B2 | plexin B2 |
| PTMN | poly(trimethylene carbonate-co-caprolactone)-b-poly(ethylene glycol) nanoparticles |
| RAD54L | RAD54-like |
| Rela | RELA proto-oncogene, NF-κB p65 subunit |
| RKIP | Raf kinase inhibitor protein |
| ROBO1 | roundabout guidance receptor 1 |
| ROS | reactive oxygen species |
| RUNX2 | runt-related transcription factor 2 |
| SCS | sulfated chitosan |
| SCT-HA | selenium-doped carbon quantum dot modified hyaluronic acid hydrogel microspheres |
| SDF-1α | stromal cell-derived factor 1α |
| SHH | sonic hedgehog |
| SIRT1 | sirtuin 1 |
| SLC7A11 | solute carrier family 7 member 11 |
| SLIT | slit guidance ligand |
| SLIT2 | slit guidance ligand 2 |
| SLIT3 | slit guidance ligand 3 |
| SnOC | senescent osteoclast |
| SNS | silicon nanosheets |
| SNS@DBM | siliconene nanosheet-modified demineralized bone matrix |
| SOX9 | SRY-box transcription factor 9 |
| STAT3 | signal transducer and activator of transcription 3 |
| TGF-β1 | transforming growth factor beta 1 |
| THVEC | type H vascular endothelial cell |
| TMJ-OA | temporomandibular joint osteoarthritis |
| TNF-α | tumor necrosis factor-alpha |
| TRAP | tartrate-resistant acid phosphatase |
| TRIM65 | tripartite motif-containing protein 65 |
| TRPM7 | transient receptor potential melastatin 7 |
| TSC1 | tuberous sclerosis complex 1 |
| VEGF | vascular endothelial growth factor |
| VEGFα | vascular endothelial growth factor A |
| YAP | Yes-associated protein |
| YSTG | Yi Shen Tiao Gan decoction |
| ZBTB16 | zinc finger and BTB domain-containing protein 16 |
| αSMA | alpha-smooth muscle actin |
| β-TCP | beta-tricalcium phosphate |